CODULLO, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.394
EU - Europa 1.095
AS - Asia 960
SA - Sud America 170
AF - Africa 23
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.650
Nazione #
US - Stati Uniti d'America 1.356
CN - Cina 470
IE - Irlanda 250
SG - Singapore 228
DE - Germania 223
RU - Federazione Russa 158
BR - Brasile 139
FI - Finlandia 139
HK - Hong Kong 126
AT - Austria 60
IT - Italia 59
VN - Vietnam 49
GB - Regno Unito 45
UA - Ucraina 40
SE - Svezia 34
IN - India 28
CA - Canada 25
JP - Giappone 20
FR - Francia 19
PL - Polonia 13
AR - Argentina 12
CZ - Repubblica Ceca 11
NL - Olanda 9
MX - Messico 8
ZA - Sudafrica 8
BE - Belgio 7
CO - Colombia 7
ES - Italia 7
IQ - Iraq 7
BD - Bangladesh 6
EC - Ecuador 5
MK - Macedonia 4
SA - Arabia Saudita 4
VE - Venezuela 4
HU - Ungheria 3
ID - Indonesia 3
KE - Kenya 3
LT - Lituania 3
MA - Marocco 3
NZ - Nuova Zelanda 3
AL - Albania 2
AU - Australia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
KR - Corea 2
MU - Mauritius 2
TN - Tunisia 2
TR - Turchia 2
UZ - Uzbekistan 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 3.650
Città #
Dublin 246
Chandler 227
Dallas 149
Munich 141
Ashburn 135
Hong Kong 125
Beijing 116
Singapore 112
Nanjing 84
Helsinki 83
Jacksonville 70
Los Angeles 54
Vienna 53
Boardman 49
New York 37
Princeton 36
Lawrence 35
Nanchang 34
Shanghai 31
Medford 28
Shenyang 27
Moscow 26
São Paulo 25
Wilmington 24
Turku 22
Pavia 21
Buffalo 19
Tokyo 19
Ho Chi Minh City 18
Seattle 18
Jiaxing 17
Milan 16
Changsha 15
Hebei 14
Hangzhou 13
Orem 13
Redondo Beach 13
Ann Arbor 12
Warsaw 12
Poplar 10
Brno 9
Chennai 9
Denver 9
Montreal 9
Santa Clara 9
The Dalles 9
Brooklyn 8
Houston 8
London 8
Tianjin 8
Brussels 7
Falkenstein 7
Hanoi 7
Norwalk 7
Pune 7
Rio de Janeiro 7
San Francisco 7
Stockholm 7
Toronto 7
Woodbridge 7
Atlanta 6
Boston 6
Chicago 6
Columbus 6
Fairfield 6
Haiphong 6
Johannesburg 6
Guangzhou 5
Jyväskylä 5
Nuremberg 5
Phoenix 5
Zhengzhou 5
Amsterdam 4
Council Bluffs 4
Düsseldorf 4
Frankfurt am Main 4
Mexico City 4
Berlin 3
Elk Grove Village 3
Juneau 3
Las Vegas 3
Manchester 3
Mumbai 3
Verona 3
Auckland 2
Baghdad 2
Biên Hòa 2
Blumenau 2
Borås 2
Calgary 2
Changchun 2
Dhaka 2
Escaudain 2
Esslingen am Neckar 2
Fuzhou 2
Guayaquil 2
Jakarta 2
Kunming 2
Medellín 2
Miami 2
Totale 2.495
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 243
B cells in rheumatoid arthritis. 122
Antinuclear antibodies in systemic sclerosis 117
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 110
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 108
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 108
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 106
B cells in rheumatoid arthritis. 106
Disease-related malnutrition in systemic sclerosis: Evidences and implications 105
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 104
Fetal programming and systemic sclerosis 98
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 98
Association of RNA Polymerase III Antibodies with Scleroderma Renal Crisis reply 93
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 90
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 88
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 86
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 85
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. 84
Undiagnosed connective tissue diseases High prevalence in pulmonary arterial hypertension patients 81
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 81
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors 80
An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. 79
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials 77
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 75
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy 74
Pathophysiology of systemic sclerosis 72
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 72
Stress doppler echocardiography in systemic sclerosis: Evidence for a role in the prediction of pulmonary hypertension 71
Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis 71
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 69
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability 69
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 68
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 68
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 67
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis 65
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 62
A 28-Year-Old Man with Stridor and Dyspnea 62
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 61
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 55
Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al 54
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway 48
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 47
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis 41
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 38
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience 37
Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange 24
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 17
Totale 3.736
Categoria #
all - tutte 16.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.504


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 14 2 19 20 15 10 2
2021/2022178 6 1 2 4 0 8 1 6 14 4 26 106
2022/2023688 71 66 12 62 58 68 1 42 273 5 22 8
2023/2024297 34 58 9 15 13 67 13 27 0 22 8 31
2024/2025975 21 45 9 22 15 90 93 81 242 41 102 214
2025/20261.016 147 103 221 227 225 93 0 0 0 0 0 0
Totale 3.736